Caraco Pharmaceutical (CPD) Granted Tentative FDA Approval for Generic Zyrtec

October 5, 2007 12:10 PM EDT

Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) said the FDA has granted tentative approval for the Company's Abbreviated New Drug Application for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg. Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.


Related Categories

FDA

Stocks Mentioned

CPD 28.74

+25.45 +773.56%
Volume: 451,365
Track CPD


Add Your Comment